New Jersey S4776 prohibits pre-authorization requirements for diabetes treatment equipment and supplies.
New Jersey S4776 mandates that health insurance carriers provide coverage for diabetes treatment equipment and supplies without prior authorization or other prospective utilization management requirements. This includes blood glucose monitors, test strips, insulin, injection aids, syringes, insulin pumps, and oral agents for controlling blood sugar. The bill also limits copayments or coinsurance for insulin to $35 per 30-day supply. It applies to individual and group health insurance policies, hospital service corporation contracts, and medical service corporation contracts.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.